000 01205 a2200337 4500
005 20250513113113.0
264 0 _c19970527
008 199705s 0 0 eng d
022 _a0277-6715
024 7 _a10.1002/sim.4780130110
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRussek-Cohen, E
245 0 0 _aSelecting the best dose when a monotonic dose-response relation exists.
_h[electronic resource]
260 _bStatistics in medicine
_cJan 1994
300 _a87-95 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aClinical Trials, Phase II as Topic
650 0 4 _aDecision Support Techniques
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Evaluation
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aModels, Statistical
650 0 4 _aRegression Analysis
650 0 4 _aResearch Design
650 0 4 _aSample Size
650 0 4 _aSurvival Analysis
650 0 4 _aZidovudine
_xtherapeutic use
700 1 _aSimon, R M
773 0 _tStatistics in medicine
_gvol. 13
_gno. 1
_gp. 87-95
856 4 0 _uhttps://doi.org/10.1002/sim.4780130110
_zAvailable from publisher's website
999 _c9049777
_d9049777